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ABSTRACT 
Background: MOSAIc is a 2-year, prospective, multi-national, observational study to determine if patient-
, physician-, and health system-related factors impact outcomes in patients with T2D and to quantify 
these relationships. This sub-analysis of baseline data aims to investigate how aspects of the patient-
physician relationship are associated with diabetes-related distress, insulin adherence and glycemic 
control. 
Methods: Patients with T2D taking insulin for ≥3 months were recruited at primary care and specialty 
practice sites in 18 countries. Physicians provided usual care. Clinical history and most recent HbA1c 
values were collected; patients were surveyed regarding their perception of physician interactions, level of 
diabetes-related distress and insulin adherence. 
Results: A total of 4341 patients were included in the analysis population. Four (of six) interpersonal 
processes of care domains showed a significant relationship with total diabetes-related distress (p<0.01). 
Poor insulin adherence was associated with greater diabetes-related distress (adjusted OR 1.14; 95% CI 
1.06-1.22), higher discrimination (1.13; 1.02-1.27) and hurried communication scores (1.35; 1.20-1.53), 
and with lower explained results score (0.86; 0.77-0.97). Poor insulin adherence was associated with a 
0.43% increase in HbA1c, and a one-unit increase in total diabetes-related distress, and hurried 
communication score was associated with a 0.171% and 0.145% increases in HbA1c, respectively. 
Conclusions: We observed poor insulin adherence when patients feel distressed about living with T2D 
and when there are aspects of their physician interactions with which they are dissatisfied. Perceived 
physician inattention and lack of engagement, as well as diabetes-related distress, have a direct 
relationship with insulin adherence and glycemic control. 
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Significant findings of the study:  
− Patient perceptions of the quality of their interactions with their physicians have a significant 
association with total diabetes-related distress. 
− Diabetes-related distress and patient-physician interactions have a significant independent 
association with insulin adherence and HbA1c level. 
 
What this study adds:  
− Delineation of the specific aspects of the patient-physician interaction that are linked to diabetes-
related distress, insulin adherence behavior and glycemic control.   
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1. INTRODUCTION 
A growing body of literature supports the positive impact of effective patient-provider communication in 
diabetes on patient outcomes. Evidence from a series of cross-sectional studies indicates that the 
patient’s relationship with his or her healthcare provider is closely related to patient self-management 
behavior.1-3 A multi-national survey of 2000 patients with diabetes found that patients’ ratings of providers’ 
communication effectiveness showed a positive relationship with self-management behavior.1 Another 
large survey of adults with diabetes that examined general- and diabetes-specific communication found 
that patients’ adherence to various self-management activities was positively associated with  healthcare 
provider communication.2 The cross-sectional Diabetes Attitudes, Wishes and Needs (DAWN) study 
assessed the relationship of self-reported well-being, self-management and diabetes control with factors 
related to patients’ healthcare of patients with type 1 (T1D) and type 2 diabetes (T2D).3 The study 
reported that better patient-provider collaboration was associated with more favorable ratings on all 
patient-reported outcome measures, including diabetes-related distress, general well-being, lifestyle and 
medical regimen adherence, perceived diabetes control and hyperglycemic symptoms.3 The second 
DAWN study (DAWN2) highlighted the need for an improvement in patient-provider interactions. For 
instance, most providers (63%) agreed that there is a major need for better availability of resources for 
the provision of psychosocial support and that providers and patients differ considerably with regard to 
their perceptions about the support being given.4 The global IntroDia™ study investigated the impact of 
early patient-physician conversations on patient self-care and self-reported outcomes. Better physician 
communication at the time of diagnosis, as recalled by patients, was linked to less diabetes distress, 
greater well-being and greater adherence to self-care behaviors.5  
 
The importance of patient-provider communication and self-care behavior is reflected in the most recent 
ADA/EASD position statement, which advocates a patient-centered approach that takes into account the 
patient’s attitude and expected treatment efforts.6 In order to be able to guide improvements and 
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healthcare provider education to improve patient-provider communication, it would be valuable to 
understand which elements of the patient-provider interaction influence self-management behavior and 
ultimately, clinical outcomes. 
 
One area of critical importance is medication adherence, and here there is specific evidence that patient-
provider communication plays a key role.5,7-10 In particular, adherence to prescribed insulin regimens is 
known to be a significant issue. For example, in a telephone survey of 1530 insulin-treated patients, one-
third of patients reported missing shots at least one day in the past month, with an average of 3.3 days.11 
These results are consistent with prior findings that patients with T2D have insulin adherence rates in the 
range of 59% to 77%.12 While we might presume that patient-physician communication plays an important 
role in adherence to insulin, we are not aware of any published research in this area.  
 
MOSAIc (Multinational Observational Study assessing Insulin use: understanding the challenges 
associated with progression of therapy) is a 2-year prospective, multi-national observational study to 
determine if patient-, physician- and health system-related factors impact treatment progression in 
patients with T2D and to quantify relationships between these factors and long-term clinical outcomes. 
The primary aim of the current baseline analysis is to investigate how key aspects of the patient-physician 
relationship may be related to patients’ levels of diabetes-related distress, insulin adherence and HbA1c 
level. Specifically, we aimed to test the hypothesis that the patient-physician interactions and diabetes-
related distress may have independent and combined effects on both insulin adherence and glycemic 
control. 
 
2. METHODS 
2.2 Study design 
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A detailed description of the MOSAIc study methods, including design, data collection, data management 
and statistical analysis, has been published.13 MOSAIc is a multi-national, prospective, observational 
cohort study of patients with T2D using insulin therapy for ≥3 months to collect real-world data, including 
demographic, clinical and psychosocial data, about patients’ care and health outcomes at regular 
intervals during a 24-month follow-up period. Physicians provide usual care to their patients, reflecting 
characteristics and patterns of patients with T2D and their treatments in real-world settings.  
 
The current analysis investigates cross-sectional associations between key psychosocial dimensions 
assessed at baseline (patients’ perspective on their interactions with their physician and diabetes 
diabetes-related distress) and insulin adherence, as well as the potential impact of these factors on 
baseline HbA1c. The conceptual model tested builds on that investigated by Heisler and colleagues1 and 
is shown in Figure 1. 
 
2.3 Patient population 
The MOSAIc study was conducted at primary care and specialty practice sites in 18 countries (Argentina; 
Brazil; Canada; China; Germany; India; Israel; Italy; Japan; Mexico; Russia; Saudi Arabia; South Korea; 
Spain; Turkey; United Arab Emirates; United Kingdom; United States, including Puerto Rico). Eligible 
patients are those ≥18 years diagnosed with T2D; taking any commercially-available insulin (except 
intensive basal-bolus insulin therapy, such as basal + 3 prandial injections) from any manufacturer for ≥3 
months with or with no combination of approved non-insulin antidiabetic medications; not simultaneously 
participating in any study with an investigational drug or procedure; proficient in the country’s primary 
language; and who provided written informed consent of study enrolment. Patients were recruited from 
both primary care practices and diabetes specialty clinics at sites in rural and urban locations and 
academic and non-academic settings. The study was conducted in accordance with the ethical principles 
that have their origin in the Declaration of Helsinki and is consistent with the applicable laws and 
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regulations of the countries where the study is being conducted. All patients completed informed consent 
forms approved by their country-specific institutional review boards. The ClinicalTrials.gov study identifier 
is NCT01400971. 
2.4 Data collection 
Retrospective data collection occurred at the baseline visit (for the period beginning six months prior to 
baseline) and prospective collection occurs during four subsequent visit windows (within ± 3 months) at 6, 
12, 18 and 24 months postbaseline. Baseline data relating to T2D clinical history, including diagnosis, 
treatment and complications and medication history, were collected from medical records. Most recently 
recorded laboratory values were recorded but limited to the period six months prior to the baseline visit. 
Information on patients’ diabetes- and insulin-related attitudes and behaviors was collected using patient 
questionnaires administered at baseline. These included the Interpersonal Processes of Care (IPC) 
survey14 and the Diabetes Distress Scale (DDS)15 to assess patients’ perceptions of their interactions with 
their physicians and their levels of diabetes-related distress, as well as additional questions to evaluate 
the current insulin regimen and insulin adherence behavior. 
 
The IPC survey was used to assess the patients’ perceptions of specific domains of the relationship with 
their physicians over the past 12 months.14 The IPC survey is a validated questionnaire developed to 
evaluate physician-patient interpersonal process of care that is designed to be suitable for diverse 
population groups and languages.14 However, one of the IPC dimensions, the 4-item disrespectful office 
staff domain, was not included in the final questionnaire battery; these results were not considered 
relevant or likely to provide accurate information given that the staff were entering the information into the 
electronic case report forms. From the 25 IPC items, six domains were assessed:16 hurried 
communication (doctors spoke too fast, used complex words, ignored what I told them, appeared 
distracted, seemed bothered if I asked several questions); elicited concerns (doctors heard my concerns 
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and took them seriously); explained results (doctors explained results of tests/examinations and 
explained the possible side effects of and consequences of not taking prescribed medicines); patient-
centered decision-making (doctors asked about preferences for helping to decide treatment and whether I 
would be able to follow the treatment); compassionate/respectful (doctors expressed concern about my 
feelings, were compassionate, supportive and respected me); discrimination (doctors made assumptions 
about my education and income status and I felt discrimination or inattentiveness due to my 
race/ethnicity). Each of the 25 items was rated by the patients on a 5-point scale, from 1 (never) to 5 
(always). For the positive IPC domains (elicited concerns, explained results, patient-centered decisions, 
compassionate/respectful), higher scores indicated more satisfying interactions. For the negative IPC 
domains (hurried communication and discrimination), lower scores indicated more satisfying interactions.  
 
The DDS is a 17-item scale for the assessment of diabetes-related emotional distress.15 The DDS is a 
validated instrument with high reliability that has been shown to be applicable to different ethnic groups.15 
Patients were asked to rate the extent to which potential problems they may experience have bothered 
them during the past month. Responses are rated on a 6-point scale, from 1 (not a problem) to 6 (a very 
serious problem). Higher scores represent greater diabetes-related distress. 
 
A series of questions were asked about the current insulin regimen and insulin adherence. The questions 
were the following: “How many times do you take your insulin a day?” with 4 response options, from once 
a day to more than three times a day, and “How often did you miss your insulin shot during the last seven 
days?” with the following response options: “I did not miss any shots,” “I missed “some, “about half,” 
“most” or “all” of my shots.”  
 
2.5 Statistical analysis 
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Descriptive summary analyses (mean, standard deviation and frequency) were reported for baseline 
characteristics, clinical variables and laboratory values, and missing values were imputed by the 
multivariate imputation by chained equations method. Countries were divided into three income groupings 
according to The World Bank definitions using gross national income per capita (lower middle income: 
$1046 to $4125, upper middle income: $4126 to $12,735 and high income: $12,736 or more).  
 
Insulin adherence was reported as complete adherence (patients who reported that missed no shots) or 
poor adherence (patients who reported missing “some,” “about half,” “most” or “all” of their insulin shots) 
during the past seven days. Due to the skewed distribution of responses, insulin adherence was analyzed 
as a binomial variable with responses split between complete and poor adherence. Unadjusted and 
adjusted regression estimates were calculated for the total distress results, insulin adherence (measured 
as frequency of missed shots) and HbA1c level. Linear regression was used for DDS and HbA1c, while 
logistic regression was used for adherence. 
 
Structural equation modeling (SEM) was used to investigate the relationships between the IPC domains, 
total distress, insulin adherence and HbA1c level. Specifically, the maximum likelihood estimator with 
robust standard errors using a numerical integration algorithm was used in path analyses for this purpose. 
SEM has been advocated over regression methods for testing mediated effects because it allows 
measurement error to be controlled for.17 Analysis-wide statistical significance was conducted at the 0.05 
level. Regression analyses were performed using SAS 9.2 (SAS, Cary, NC, USA) and SEM was 
performed using Mplus 7.3 (Mplus, Los Angeles, CA, USA). 
 
3. RESULTS 
3.1 Patient characteristics 
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A total of 4341 patients met MOSAIc eligibility criteria and were included in the analysis population. Mean 
patient age was 61.8 years, 50% were female, mean T2D duration was 12.7 years and mean baseline 
HbA1c was 8.1%. Of note, 76% of the sample reported that they missed no insulin injections during the 
previous week. An overview of the baseline characteristics and pooled results for the IPC and DDS 
questionnaires are shown in Table 1. Further details about baseline characteristics for the MOSAIc study 
sample have been published elsewhere.17 
 
3.2 The influence of patient-physician communication on diabetes-related distress 
Higher scores in the two negative IPC domains (hurried communication and discrimination) were 
independently linked with greater diabetes-related distress (Table 2). In addition, higher scores in two of 
the positive IPC domains (explained results and patient-centered decision-making) were independently 
associated with lower levels of diabetes-related distress. Hurried communication showed a markedly 
stronger association with diabetes-related distress than any other IPC domain (adjusted regression 
estimate 0.40; p<0.001). 
 
3.3 The influence of patient-physician communication and diabetes distress on insulin adherence 
Greater likelihood of missed insulin injections was independently associated with higher scores on the 
two negative IPC domains (hurried communication [adjusted OR1.35; 95% CI 1.20-1.53] and 
discrimination [adjusted OR 1.13; 95% CI 1.02-1.27]), with lower scores on one of the positive IPC 
domains (less time spent having medical tests and results explained [adjusted OR 0.86; 95% CI 0.77-
0.97] and with greater diabetes-related distress [adjusted OR 1.14; 95% CI 1.06-1.22]) (Table 3). 
 
3.4 The influence of patient-physician communication, diabetes-related distress and insulin 
adherence on HbA1c 
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Higher HbA1c level was independently linked with diabetes-related distress (adjusted regression estimate 
0.12; p<0.01), the hurried communication domain of the IPC scale (adjusted regression estimate 0.16; 
p<0.01) and poor insulin adherence (adjusted regression estimate 0.31; p<0.001) (Table 4). 
 
3.5 Modeling the associations between HbA1c, insulin adherence and psychosocial factors 
Structural equation modeling was performed to estimate the relationships between aspects of patient-
physician communication, diabetes-related distress, insulin adherence and HbA1c level. The path 
analysis (Figure 2) shows the parameter coefficients for the interactions between these factors. Paths 
from four of the IPC domains (patient-centered decision-making, discrimination, explained results and 
hurried communication) to total diabetes-related distress were significant and in the predicted direction, 
with a particularly high proportion of diabetes-related distress explained by the hurried communication 
domain (parameter coefficient 0.414). 
 
Variance in insulin adherence behavior was explained by three of the same IPC domains (discrimination, 
explained results and hurried communication) and by diabetes-related distress. A single-unit increase in 
the total distress score was associated with an 18% increase in the likelihood of poor insulin adherence 
(parameter coefficient 0.168; OR 1.18). Single-unit increases in the hurried communication and 
discrimination domain scores were associated with 29% and 19% increased odds of poor insulin 
adherence (parameter coefficients 0.254 and 0.176; ORs 1.29 and 1.19, respectively), while the same 
increase in the explained results domain was associated with a 15% reduction in the odds of poor insulin 
adherence (parameter coefficient -0.158; OR 1.15).  
 
Insulin adherence behavior explained a substantial proportion of HbA1c level, with poor insulin adherence 
linked with a 0.43% increase in HbA1c. Diabetes-related distress and hurried communication were also 
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linked directly with HbA1c level, with a single-unit increase in each associated with a 0.171% and 0.145% 
increase in HbA1c, respectively. 
 
4. DISCUSSION 
This baseline analysis of cross-sectional data obtained as part of the global MOSAIc study demonstrated, 
through regression analyses and structural equation modeling, a significant relationship between aspects 
of the patient-physician relationship, insulin adherence and HbA1c level (Figure 2). We observed more 
problematic insulin adherence when patients were distressed about living with T2D and when there were 
aspects of their interactions with their physicians with which they were dissatisfied.  
 
Problematic insulin adherence was associated with a 0.43% increase in HbA1c level, confirming the 
findings of other studies that have reported a significant relationship between medication adherence and 
HbA1c.19 In terms of the factors that drive insulin adherence, various domains of the patient-physician 
relationship, as well as total distress, were shown to influence the likelihood of missing insulin shots. In 
particular, a patient’s perception of hurried communication showed a substantial effect on insulin 
adherence, with a 29% increased likelihood of a patient missing at least some insulin shots associated 
with a single-unit increase in the score for hurried communication by their physician. The hurried 
communication domain provides a measure of not only how quickly the physician spoke, but also the 
patient’s perception of whether the physician used complex words, appeared distracted, seemed 
bothered when the patient asked questions or ignored the patient’s input. This could also be described as 
a measure of the physician’s perceived lack of engagement or inattentiveness during consultations. The 
explained results domain assessed whether the physician explained the results of examinations and 
tests, and importantly, whether he or she informed the patient of the possible side effects of prescribed 
medicines and the consequences of not adhering to the prescribed treatment regimen. 
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Our study results build on prior research and demonstrate the importance of healthcare professionals’ 
communication skills and style on patients’ emotional response to their condition, insulin adherence 
behavior and HbA1c level. Mayberry and Osborn tested an information-motivation-behavioral skills (IMB) 
model, the elements of which explained 41% of the variability in medication adherence behavior. The 
elements of the IMB model were adherence information, adherence motivation and adherence behavior 
skills.19 In this study, we investigated the impact of patient-physician communication on insulin 
adherence, rather than overall medication adherence. We also looked at specific aspects of the patient-
physician interaction that allowed us to reveal the particularly important effect of the hurried 
communication, explained results and discrimination domains. The impact of these particular aspects of 
the patient-physician interaction is supported by findings from several other studies,1,3 including the 
TRIAD study that investigated barriers to insulin initiation in patients with T2D.7 In the TRIAD study, a 
significantly greater proportion of patients who failed to initiate prescribed insulin treatment reported the 
following about their physician interactions: compared with those who initiated, patients who did not 
initiate treatment more frequently reported that the risks and benefits of treatment were not well explained 
and a higher proportion had inadequate health literacy and reported having problems learning about their 
medical condition.7 The importance of patient-physician interactions is further underscored by the Forum 
for Injection Technique recommendations, which include guidelines for patient-physician communication 
aimed at achieving optimal injection technique.20 
 
Given the many competing priorities during time-limited patient consultations, the complexity of the 
disease and the factors that influence clinical outcomes, consideration for longer consultation times for 
the management of T2D is warranted by health policy makers. However, our findings suggest that 
identifying and implementing strategies to enhance physician engagement or attentiveness and the 
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quality of explanation regarding medical tests, their results and the pros and cons of the prescribed 
treatment regimen should be key focus areas in improving insulin adherence for patients with T2D.  
 
The importance of the patient’s experience interacting with their physician is further underscored by the 
direct association we reported between the patient-physician interaction and HbA1c level. The measure 
of physician inattentiveness showed a direct relationship with glycemic control that was separate from the 
impact on insulin adherence, lending support to the concept of patient empowerment. Perhaps having 
consultations with a physician who appears engaged, attentive and willing to answer questions is more 
likely to engage and support patients’ interests and confidence in their own diabetes self-management, 
above and beyond careful attention to their insulin regimen. In support of this hypothesis, in one 
randomized, controlled trial, patients with diabetes who were coached to ask more questions and be more 
proactive in raising concerns during medical consultations, thereby prompting better engagement and 
attentiveness during the visit, had significantly better biomedical outcomes, including better glycemic 
control.21  
 
One limitation of the current study was that insulin adherence was analyzed as a binomial outcome 
measure, with all responses indicating any degree of less-than-optimal adherence (≥1 missed shot/week) 
grouped together. This prevents us from distinguishing between patients with different degrees of poor 
adherence and the potential relationship that this may have on clinical outcomes. Also, given the cross-
sectional nature of these findings, causal inferences cannot be made. Furthermore, patient-physician 
differences in gender and language, which can play important roles in medication adherence,22,23 were 
not assessed. Still, a significant relationship was identified between aspects of the patient-physician 
relationship, diabetes-related distress, insulin adherence and HbA1c level. These data support the 
hypothesis that interactions between the patient and physician and diabetes-related distress may have a 
direct negative impact on insulin adherence and HbA1c level. Given the independent effect of patient-
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physician interactions on HbA1c, we would expect to find that there are other mechanisms involved 
beyond adherence to insulin regimens. Further investigations are being conducted over a 2-year period 
and will explore the involvement of other factors, such as diabetes knowledge and increase in self-care 
activities, as well as a careful examination of the temporal relationship between these factors. 
 
The findings of this study point to a clear relationship between diabetes-related distress and aspects of 
patient-physician interactions with insulin adherence in patients with T2D. Patients’ perceptions of 
physician engagement and attentiveness, the quality of explanation about medical tests and results and 
discussion around the prescribed treatment regimen were directly associated with insulin adherence 
behavior. Diabetes-related distress and physician engagement and attentiveness were also shown to be 
independently linked to long-term glycemic control. Given the cross-sectional nature of this study, the 
direction of the relationships between patient-physician communication, level of diabetes-related distress 
and insulin adherence cannot be determined. However, the current findings are consistent with previous 
data suggesting that improving patient-physician interactions may help improve insulin adherence.24 Our 
findings suggest that efforts to enhance physician engagement and attentiveness, explanation of medical 
tests and their results and discussion about the possible impact of the prescribed clinical management 
approach are warranted. 
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FIGURE LEGENDS 
Figure 1. Conceptual model tested: hypothesis for how patient perception of care influences distress 
status, insulin adherence and the relationship with clinical outcomes.  
Figure 2. Path analysis showing interaction between patient-physician interaction, diabetes-related 
distress, insulin adherence and HbA1c level. Model not adjusted for baseline covariates and showing only 
those factors with at least one significant interaction. 
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Table 1. Patient characteristics and Interpersonal Processes of Care, diabetes-related distress and 
insulin adherence results for patients enrolled in the MOSAIc study at baseline 
Age, years Mean (SD) 61.77 (11.02) 
Gender, female n (%) 2176 (50.13) 
Duration of diabetes (years) Mean (SD) 12.65 (7.98) 
HbA1c,% Mean (SD) 8.13 (1.75) 
Country income level 
Low middle 
Upper middle 
High 
 
n (%) 
n (%) 
n (%) 
 
918 (21.15) 
1177 (27.11) 
2246 (51.74) 
Education level 
Primary 
High school 
College 
 
n (%) 
n (%) 
n (%) 
 
1291 (29.74) 
1216 (28.01) 
1499 (34.53) 
Insurance status 
Uninsured 
Private  
Public 
 
n (%) 
n (%) 
n (%) 
 
848 (19.53) 
917 (21.12) 
2229 (51.35) 
Interpersonal Processes of Care 
Hurried communication 
Elicited concerns 
Explained results 
Patient-centered decision making 
Compassionate-respectful 
Discrimination 
 
Mean (SD) 
Mean (SD) 
Mean (SD) 
Mean (SD) 
Mean (SD) 
Mean (SD) 
 
1.58 (0.70) 
3.92 (1.04) 
3.92 (1.01) 
3.36 (1.21) 
4.10 (0.88) 
1.51 (0.73) 
Diabetes distress scale 
Total distress 
 
Mean (SD) 
 
2.27 (1.13) 
Insulin treatment regimen 
Number of shots per day 
Once per day 
Twice per day 
Three times per day 
More than three times per day 
 
Mean (SD) 
n (%) 
n (%) 
n (%) 
n (%) 
 
1.63 (0.68) 
1977 (45.54) 
1921 (44.25) 
244 (5.62) 
77 (1.77) 
Insulin adherence, missed insulin shots in last 7 
days 
I did not miss any shots 
I missed some / about half / most / all shots 
 
 
n (%) 
n (%) 
 
 
3290 (75.79) 
927 (21.35) 
 
HbA1c, glycated hemoglobin; SD, standard deviation
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Table 2. Unadjusted and adjusted regression estimates for the impact of patient characteristics and 
Interpersonal Processes of Care scores on diabetes-related distress. 
 Diabetes-related distress 
 
Unadjusted regression 
estimate (95% CI) 
Adjusted regression  
estimate (95% CI) 
Age -0.02*** (-0.02, -0.01) -0.02*** (-0.02, -0.01) 
Gender, female  0.14*** (0.07, 0.20)  0.11*** (0.04, 0.17) 
Diabetes duration -0.01*** (-0.01, -0.00)  0.00 (-0.00, 0.01) 
Country income 
Upper middle 
High 
 
 0.18*** 
-0.00 
 
(0.08, 0.28) 
(-0.09, 0.08) 
 
 0.19** 
 0.06 
 
(0.09, 0.30) 
(-0.03, 0.15) 
Education level 
High school 
College 
 
-0.08 
 0.05 
 
(-0.17, 0.01) 
(-0.03, 0.14) 
 
-0.02 
 0.06 
 
(-0.11, 0.06) 
(-0.03, 0.14) 
Insurance status 
Public  
Private 
 
 0.13** 
-0.01 
 
(0.04, 0.22) 
(-0.11, 0.10) 
 
 0.09 
 0.04 
 
(-0.00, 0.18) 
(-0.06, 0.14) 
Interpersonal Processes of Care 
Hurried communication 
Elicited concerns 
Explained results 
Patient-centered decision making 
Compassionate/respectful 
Discrimination 
 
 0.42*** 
 0.01 
-0.07** 
-0.05** 
-0.04 
 0.17*** 
 
(0.37, 0.47) 
(-0.03, 0.05) 
(-0.12, -0.03) 
(-0.09, -0.02) 
(-0.09, 0.01) 
(0.12, 0.21) 
 
 0.40*** 
 0.02 
-0.07** 
-0.07*** 
-0.03 
 0.16*** 
 
(0.35, 0.46) 
(-0.02, 0.06) 
(-0.12, -0.02) 
(-0.10, -0.03) 
(-0.08, 0.02) 
(0.11, 0.21) 
 
CI, confidence interval. Significance levels are indicated as: * p<0.05; ** p<0.01; *** p<0.001. Adjusted 
regression model includes all parameters (age, gender, diabetes duration, country income, education 
level, insurance status, interpersonal processes of care domain results). Low middle country income, 
primary education level and uninsured insurance status served as reference groups for the regression 
analysis and are not shown in the table. 
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Table 3. Unadjusted and adjusted regression estimates for the impact of patient characteristics, 
Interpersonal Processes of Care scores and diabetes-related distress on adherence, measured as 
missed shots. 
 Insulin adherence 
 Unadjusted OR  
(95% CI) 
Adjusted OR  
(95% CI) 
Age 0.96*** (0.95, 0.97) 0.97*** (0.96, 0.98) 
Gender, female 0.89 (0.77, 1.03) 0.90 (0.77, 1.06) 
Diabetes duration 0.97*** (0.96, 0.98) 0.99* (0.98, 1.00) 
Country income 
Upper middle 
High 
 
0.83 
0.60*** 
 
(0.68, 1.01) 
(0.50, 0.72) 
 
0.94 
0.77* 
 
(0.74, 1.20) 
(0.62, 0.96) 
Education level 
High school 
College 
 
1.22* 
1.42*** 
 
(1.00, 1.48) 
(1.19, 1.71) 
 
1.12 
1.18 
 
(0.90, 1.38) 
(0.97, 1.45) 
Insurance status 
Public  
Private 
 
0.84 
1.29* 
 
(0.70, 1.02) 
(1.04, 1.60) 
 
0.95 
1.42** 
 
(0.76, 1.19) 
(1.12, 1.79) 
Interpersonal Processes of Care 
Hurried communication 
Elicited concerns 
Explained results 
Patient-centered decision making 
Compassionate/respectful 
Discrimination 
 
1.36*** 
0.95 
0.85** 
1.06 
1.01 
1.24*** 
 
(1.21, 1.52) 
(0.87, 1.04) 
(0.76, 0.94) 
(0.97, 1.16) 
(0.90, 1.13) 
(1.12, 1.38) 
 
1.35*** 
0.93 
0.86* 
1.03 
1.08 
1.13 
 
(1.20, 1.53) 
(0.85, 1.02) 
(0.77, 0.97) 
(0.94, 1.13) 
(0.96, 1.22) 
(1.02, 1.27) 
Diabetes-related distress 1.29*** (1.21, 1.37) 1.14*** (1.06, 1.22) 
Insulin treatment regimen 
Number of shots per day 
 
1.25*** 
 
(1.12, 1.39) 
 
1.23*** 
 
(1.10, 1.37) 
 
CI, confidence interval; OR, odds ratio. Significance levels are indicated as: * p<0.05; ** p<0.01; *** 
p<0.001. Adjusted regression model includes all parameters (age, gender, diabetes duration, country 
income, education level, insurance status, interpersonal processes of care domain results). Low middle 
country income, primary education level and uninsured insurance status served as reference groups for 
the regression analysis and are not shown in the table.  
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Table 4. Unadjusted and adjusted regression estimates of the impact of patient characteristics, 
Interpersonal Processes of Care, diabetes-related distress, and insulin adherence on HbA1c level. 
 HbA1c 
 
Unadjusted regression 
estimate (95% CI) 
Adjusted regression 
estimate (95% CI) 
Age -0.02*** (-0.03, -0.02) -0.02*** (-0.02, -0.01) 
Gender, female  0.11 (-0.01, 0.23)  0.08 (-0.04, 0.21) 
Diabetes duration -0.01 (-0.01, 0.00)  0.00 (-0.00, 0.01) 
Country income 
Upper middle 
High 
 
-0.34*** 
-0.51*** 
 
(-0.53, -0.15) 
(-0.69, -0.34) 
 
-0.47*** 
-0.45*** 
 
(-0.70, -0.24) 
(-0.66, -0.25) 
Education level 
High school 
College 
 
-0.12 
-0.19* 
 
(-0.28, 0.04) 
(-0.36, -0.03) 
 
-0.20* 
-0.30** 
 
(-0.36, -0.03) 
(-0.48, -0.12) 
Insurance status 
Public 
Private 
 
-0.28** 
-0.22 
 
(-0.46, -0.09) 
(-0.48, 0.04) 
 
-0.05 
-0.04 
 
(-0.27, 0.16) 
(-0.30, 0.23) 
Interpersonal Processes of Care 
Hurried communication 
Elicited concerns 
Explained results 
Patient-centered decision making 
Compassionate/respectful 
Discrimination 
 
 0.18*** 
 0.01 
-0.04 
 0.03 
-0.03 
-0.00 
 
(0.08, 0.28) 
(-0.08, 0.11) 
(-0.15, 0.06) 
(-0.06, 0.11) 
(-0.14, 0.07) 
(-0.11, 0.11) 
 
 0.16** 
 0.01 
-0.02 
 0.04 
-0.00 
-0.11 
 
(0.05, 0.26) 
(-0.08, 0.10) 
(-0.12, 0.09) 
(-0.05, 0.12) 
(-0.12, 0.11) 
(-0.22, 0.00) 
Diabetes-related distress  0.17*** (0.11, 0.23)  0.12** (0.05, 0.19) 
Insulin adherence 
Missed shots 
 
0.46*** 
 
(0.32, 0.60) 
 
 0.31*** 
 
(0.17, 0.45) 
Insulin treatment regimen 
Number of shots per day 
 
0.20*** 
 
(0.10, 0.30) 
 
 0.15** 
 
(0.05, 0.24) 
 
CI, confidence interval; HbA1c, glycated hemoglobin. Significance levels are indicated as: * p<0.05;  
** p<0.01; *** p<0.001. Adjusted regression model includes all parameters (age, gender, diabetes 
duration, country income, education level, insurance status, interpersonal processes of care domain 
results). Low middle country income, primary education level and uninsured insurance status served as 
reference groups for the regression analysis and are not shown in the table. 
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